Florence Pasquier

Featured in: Favicon

Articles

Olutasidenib for Adults with Relapsed or Refractory Acute Myeloid Leukaemia with Isocitrate Dehydrogenase 1 Mutation

Mar 7, 2024 | touchoncology.com | Florence Pasquier |Stephane de Botton

Leukaemia Read Time: 14 mins Copy Link Published Online: Mar 7th 2024 touchREVIEWS in Oncology & Haematology. 2024;20(1):1–5:Online ahead of journal publication Authors: Florence Pasquier, Stéphane De Botton Quick Links: Overview Management of patients with relapsed or refractory (R/R) acute myeloid leukaemia (AML) is challenging, as their prognosis remains poor with conventional therapies, underlining the need for the development of new drugs.
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores - Nature Communications

Feb 9, 2023 | nature.com | Itziar de Rojas |Najada Stringa |Anna Zettergren |Rebecca Sims |Céline Bellenguez |Miguel Calero | +79 more

Author notesThese authors contributed equally: Itziar de Rojas, Sonia Moreno-Grau, Niccolo Tesi, Benjamin Grenier-Boley, Victor Andrade, Iris E. Jansen. These authors jointly supervised this work: Jordi Clarimón, Mercè Boada, Wiesje M. van der Flier, Alfredo Ramirez, Jean-Charles Lambert, Sven J. van der Lee, Agustín Ruiz.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.